Thursday, August 20, 2026

Daily Docket: Social Media Intake Leads a Five-Front Filing Push

Platform-harm claims commanded the day’s intake, with Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047) logging 36 filings as Wright & Schulte LLC lodged 16 and Keller Postman LLC added 14. Zantac Products Liability Litigation (2924) produced 21 transfer-in matters, all through Keller Postman LLC, while Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (3060) added 20 cases split between Morgan & Morgan PA and Peiffer Wolf at five apiece. Lyft Passenger Sex Assault Litigation (3171) recorded 16 filings, all by Williams Hart & Boundas LLP, concentrating the docket’s current activity in a firm already positioned around the dispute’s document-production track. Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability (Gastroparesis) Litigation (3094) added 14 matters, led by Morgan & Morgan PA’s six and Seeger Weiss’ five, extending the coordinated intake around alleged gastrointestinal injuries. See the full filing feed and firm-level breakdowns here.

Former Meta Engineer Puts Child-Safety Evidence Before Federal Jury

At the Aug. 19 trial session, former Meta engineering director Arturo Béjar testified that the company elevated growth and engagement over safeguards for children using Instagram and Facebook. Béjar told jurors that Meta could identify many potentially underage users but took a “don’t ask, don’t tell” approach, placing internal product choices and executive knowledge directly at issue. The testimony arose in the states’ separate federal action against Meta, not a bellwether in Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047). But the live examination of internal safety practices, youth-user data and executive decision-making can sharpen the discovery and proof disputes confronting platform defendants across the broader youth-harms litigation.

D.C. Circuit Preserves EPA’s PFAS Hazardous-Substance Designation

The D.C. Circuit on Aug. 18 upheld EPA’s designation of PFOA and PFOS, including their salts and structural isomers, as CERCLA hazardous substances. The appellate ruling leaves federal reporting and Superfund-response authorities intact for releases involving those chemicals while preserving site-specific fights over cleanup and allocation. That keeps a central regulatory liability framework in place as parties litigate contamination, remediation and corporate-knowledge theories in Aqueous Film-Forming Foams Products Liability Litigation (2873). The decision does not impose automatic liability for every PFAS-containing product or contaminated property, but it preserves a federal enforcement lever that can materially affect exposure and settlement posture.